Analytical Data
-
Gene name
BAI3
- Application
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O60242
-
Expression Region
Cys30~Pro508
-
Molecular Weight
58kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BAI3 (Brain-specific Angiogenesis Inhibitor 3) is a member of the BAI family of G protein-coupled receptors (GPCRs) that has garnered attention due to its unique role in the central nervous system and its potential implications in various neurological disorders. Research on BAI3 has indicated its involvement in regulating angiogenesis, neuronal signaling, and synaptic processes, which are critical for maintaining neural homeostasis. The receptor's distinct expression patterns in the brain suggest its specific functions in neurodevelopment and neuroplasticity. Furthermore, mutations or dysregulation of BAI3 have been implicated in conditions such as schizophrenia, depression, and other neurodegenerative diseases. Thus, understanding the structure and function of BAI3, particularly through studies on its recombinant protein form, holds promise for deciphering its biological roles and therapeutic potential. By employing techniques such as molecular cloning, protein expression, and functional assays, researchers aim to elucidate the signaling pathways mediated by BAI3 and explore its interactions with other cellular components. This knowledge could pave the way for novel strategies in targeting BAI3 for therapeutic interventions in mental health and neurodegenerative disorders, highlighting its significance in contemporary biomedical research.
